These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 20561979)
1. Resveratrol protects against peripheral deficits in a mouse model of Huntington's disease. Ho DJ; Calingasan NY; Wille E; Dumont M; Beal MF Exp Neurol; 2010 Sep; 225(1):74-84. PubMed ID: 20561979 [TBL] [Abstract][Full Text] [Related]
2. Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington's disease following chronic energy deprivation. Chaturvedi RK; Calingasan NY; Yang L; Hennessey T; Johri A; Beal MF Hum Mol Genet; 2010 Aug; 19(16):3190-205. PubMed ID: 20529956 [TBL] [Abstract][Full Text] [Related]
3. Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration. Weydt P; Pineda VV; Torrence AE; Libby RT; Satterfield TF; Lazarowski ER; Gilbert ML; Morton GJ; Bammler TK; Strand AD; Cui L; Beyer RP; Easley CN; Smith AC; Krainc D; Luquet S; Sweet IR; Schwartz MW; La Spada AR Cell Metab; 2006 Nov; 4(5):349-62. PubMed ID: 17055784 [TBL] [Abstract][Full Text] [Related]
4. Neuroprotective and metabolic effects of resveratrol: therapeutic implications for Huntington's disease and other neurodegenerative disorders. Pasinetti GM; Wang J; Marambaud P; Ferruzzi M; Gregor P; Knable LA; Ho L Exp Neurol; 2011 Nov; 232(1):1-6. PubMed ID: 21907197 [TBL] [Abstract][Full Text] [Related]
5. Transducer of regulated CREB-binding proteins (TORCs) transcription and function is impaired in Huntington's disease. Chaturvedi RK; Hennessey T; Johri A; Tiwari SK; Mishra D; Agarwal S; Kim YS; Beal MF Hum Mol Genet; 2012 Aug; 21(15):3474-88. PubMed ID: 22589249 [TBL] [Abstract][Full Text] [Related]
6. Resveratrol alleviates diabetic cardiomyopathy in rats by improving mitochondrial function through PGC-1α deacetylation. Fang WJ; Wang CJ; He Y; Zhou YL; Peng XD; Liu SK Acta Pharmacol Sin; 2018 Jan; 39(1):59-73. PubMed ID: 28770830 [TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of PPAR-γ agonist rosiglitazone in N171-82Q mouse model of Huntington's disease. Jin J; Albertz J; Guo Z; Peng Q; Rudow G; Troncoso JC; Ross CA; Duan W J Neurochem; 2013 May; 125(3):410-9. PubMed ID: 23373812 [TBL] [Abstract][Full Text] [Related]
9. Pharmacologic activation of mitochondrial biogenesis exerts widespread beneficial effects in a transgenic mouse model of Huntington's disease. Johri A; Calingasan NY; Hennessey TM; Sharma A; Yang L; Wille E; Chandra A; Beal MF Hum Mol Genet; 2012 Mar; 21(5):1124-37. PubMed ID: 22095692 [TBL] [Abstract][Full Text] [Related]
10. Nicotinamide improves motor deficits and upregulates PGC-1α and BDNF gene expression in a mouse model of Huntington's disease. Hathorn T; Snyder-Keller A; Messer A Neurobiol Dis; 2011 Jan; 41(1):43-50. PubMed ID: 20736066 [TBL] [Abstract][Full Text] [Related]
11. Activation of peroxisome proliferator-activated receptor-γ coactivator 1α ameliorates mitochondrial dysfunction and protects podocytes from aldosterone-induced injury. Yuan Y; Huang S; Wang W; Wang Y; Zhang P; Zhu C; Ding G; Liu B; Yang T; Zhang A Kidney Int; 2012 Oct; 82(7):771-89. PubMed ID: 22648295 [TBL] [Abstract][Full Text] [Related]
13. Resveratrol Reduces Oxidative Stress and Apoptosis in Podocytes via Sir2-Related Enzymes, Sirtuins1 (SIRT1)/Peroxisome Proliferator-Activated Receptor γ Co-Activator 1α (PGC-1α) Axis. Zhang T; Chi Y; Ren Y; Du C; Shi Y; Li Y Med Sci Monit; 2019 Feb; 25():1220-1231. PubMed ID: 30765684 [TBL] [Abstract][Full Text] [Related]
14. AMP-activated protein kinase mediates activity-dependent regulation of peroxisome proliferator-activated receptor gamma coactivator-1alpha and nuclear respiratory factor 1 expression in rat visual cortical neurons. Yu L; Yang SJ Neuroscience; 2010 Aug; 169(1):23-38. PubMed ID: 20438809 [TBL] [Abstract][Full Text] [Related]
15. Activating mitochondrial regulator PGC-1α expression by astrocytic NGF is a therapeutic strategy for Huntington's disease. Chen LW; Horng LY; Wu CL; Sung HC; Wu RT Neuropharmacology; 2012 Sep; 63(4):719-32. PubMed ID: 22633948 [TBL] [Abstract][Full Text] [Related]
16. Developmental alterations in motor coordination and medium spiny neuron markers in mice lacking pgc-1α. Lucas EK; Dougherty SE; McMeekin LJ; Trinh AT; Reid CS; Cowell RM PLoS One; 2012; 7(8):e42878. PubMed ID: 22916173 [TBL] [Abstract][Full Text] [Related]
17. The diabetes medication canagliflozin promotes mitochondrial remodelling of adipocyte via the AMPK-Sirt1-Pgc-1α signalling pathway. Yang X; Liu Q; Li Y; Tang Q; Wu T; Chen L; Pu S; Zhao Y; Zhang G; Huang C; Zhang J; Zhang Z; Huang Y; Zou M; Shi X; Jiang W; Wang R; He J Adipocyte; 2020 Dec; 9(1):484-494. PubMed ID: 32835596 [TBL] [Abstract][Full Text] [Related]
18. Resveratrol induces expression of the slow, oxidative phenotype in mdx mouse muscle together with enhanced activity of the SIRT1-PGC-1α axis. Ljubicic V; Burt M; Lunde JA; Jasmin BJ Am J Physiol Cell Physiol; 2014 Jul; 307(1):C66-82. PubMed ID: 24760981 [TBL] [Abstract][Full Text] [Related]
19. SIRT1 Activation by Resveratrol Alleviates Cardiac Dysfunction via Mitochondrial Regulation in Diabetic Cardiomyopathy Mice. Ma S; Feng J; Zhang R; Chen J; Han D; Li X; Yang B; Li X; Fan M; Li C; Tian Z; Wang Y; Cao F Oxid Med Cell Longev; 2017; 2017():4602715. PubMed ID: 28883902 [TBL] [Abstract][Full Text] [Related]
20. mRNA expression levels of PGC-1α in a transgenic and a toxin model of Huntington's disease. Török R; Kónya JA; Zádori D; Veres G; Szalárdy L; Vécsei L; Klivényi P Cell Mol Neurobiol; 2015 Mar; 35(2):293-301. PubMed ID: 25319408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]